Ticker: SNDA

Sonida Senior Living

Healthcare Healthcare Medical - Care Facilities
Price 39.78
Reco Sell Potential 50 Risk 70 Updated 2026-09-10

Forecast impact

limited
Target +8.7% target fill 92.0%
Reaction D5 +4.05% · D10 pending fresh confirmed · market trust
Impact Potential 0 · Risk 0 valid until 2026-10-03

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

Sonida Senior Living operates in the healthcare sector, focusing on providing senior living services. Its core offerings include independent living, assisted living, and memory care facilities. The company generates revenue primarily through rental income from its residential units and ancillary services tailored for seniors. Sonida aims to enhance the quality of life for its residents while maintaining operational efficiency across its properties.

Investment Profile

The investment profile of Sonida Senior Living is more aligned with balanced investors, given its focus on stability and potential for moderate growth. The company has shown a significant revenue increase, indicating operational improvement, but its negative earnings per share suggests caution. Investors may find it suitable for a medium-term horizon, with moderate liquidity considerations.

Fundamental metrics (experimental) Updated: 2026-09-10
EPS (TTM) — earnings per share for the last 12 months, $
-7.02
Revenue QoQ — quarter-over-quarter revenue growth
69.3%
EPS surprise
-8.3%
20d volatility
2.1%
AI recommendation changes
Date Before After Reason
2026-08-18 Hold Sell Weak fundamentals and negative momentum raise significant concerns.
2026-08-11 Sell Hold Strong revenue growth, but negative EPS raises concerns.
2026-07-30 Hold Sell Weak fundamentals and high risk limit upside potential.
Analyst forecasts
Date Analyst Action Target Price Then
2026-09-03 Robert W. Baird Rating Upgraded — → 43 37.88
2026-09-01 Morgan Stanley Target Raised 38 → 44 37.5
2026-08-11 Cantor Fitzgerald Target Raised 42 → 47 41.99
News Page 1 of 1
Rhythm Pharmaceuticals Sonida Senior Living Ford Motor Company Rivian Anheuser-Busch InBev Cameco Mobileye Global Williams-Sonoma General Motors

Analysts Piper Sandler upgrade Rivian (RIVN) and Mobileye (MBLY) to Overweight, citing strong demand outlooks

Recent analyst upgrades and initiations across various sectors indicate a positive outlook for several companies, including Rivian, Mobileye, and Williams-Sonoma, suggesting potential investment opportunities for investors.